NexDx Appoints V. Michael Holers, M.D. and Robert Plenge, M.D., Ph.D. to Scientific Advisory Board

The two internationally renowned physician-scientists will help guide NexDx's development of molecular diagnostics in rheumatoid arthritis and other autoimmune diseases.San Diego, CA (PRWEB) September 14, 2012 NexDx, Inc. (http://www.nexdx.com), a science driven molecular diagnostics company providing next generation products and services for personalized medicine in rheumatoid arthritis and … Continue reading

NexDx Raises $2.6 million in Series B Financing and Capital Term Loan

San Diego biotech NexDx, Inc., successfully closed a $2.1 million Series B financing led by founding investor, City Hill Ventures, LLC, and a $500,000 capital term loan from Silicon Valley Bank.San Diego, CA (PRWEB) June 29, 2012 NexDx, Inc., a science driven molecular diagnostics company providing next generation products and services for personalized medicine in rheumatoid arthritis and other … Continue reading